3. Umbruch 4.4..2005 - Online Pot

136 S.A. Varvel and A.H. Lichtman
82 Egertova M, Elphick MR (2000) Localisation of cannabinoid receptors in the rat brain using antibodies
to the intracellular C-terminal tail of CB(1). J Comp Neurol 422: 159–171
83 Felder CC, Nielsen A, Briley EM, Palkovits M, Priller J, Axelrod J, Nguyen DN, Richardson JM,
Riggin RM, Koppel GA et al. (1996) Isolation and measurement of the endogenous cannabinoid
receptor agonist, anandamide, in brain and peripheral tissues of human and rat. FEBS Lett 393:
231–235
84 Bisogno T, Berrendero F, Ambrosino G, Cebeira M, Ramos JA, Fernandez-Ruiz JJ, Di Marzo V
(1999) Brain regional distribution of endocannabinoids: implications for their biosynthesis and
biological function. Biochem Biophys Res Commun 256: 377–380
85 Egertova M, Giang DK, Cravatt BF, Elphick MR (1998) A new perspective on cannabinoid signalling:
complementary localization of fatty acid amide hydrolase and the CB1 receptor in rat
brain. Proc R Soc Lond B Biol Sci 265: 2081–2085
86 Tsou K, Nogueron MI, Muthian S, Sanudo-Pena MC, Hillard CJ, Deutsch DG, Walker JM (1998)
Fatty acid amide hydrolase is located preferentially in large neurons in the rat central nervous system
as revealed by immunohistochemistry. Neurosci Lett 254: 137–140
87 Dinh TP, Carpenter D, Leslie FM, Freund TF, Katona I, Sensi SL, Kathuria S, Piomelli D (2002)
Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci
USA 99: 10819–10824
88 Dinh TP, Freund TF, Piomelli D (2002) A role for monoglyceride lipase in 2-arachidonoylglycerol
inactivation. Chem Phys Lipids 121: 149–158
89 Di Marzo V, Breivogel CS, Tao Q, Bridgen DT, Razdan RK, Zimmer AM, Zimmer A, Martin BR
(2000) Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid
receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide
in mouse brain. J Neurochem 75: 2434–2444
90 Egashira N, Mishima K, Iwasaki K, Fujiwara M (2002) Intracerebral microinjections of delta
9-tetrahydrocannabinol: search for the impairment of spatial memory in the eight-arm radial
maze in rats. Brain Res 952: 239–245
91 Pistis M, Ferraro L, Pira L, Flore G, Tanganelli S, Gessa GL, Devoto P (2002) Delta(9)-tetrahydrocannabinol
decreases extracellular GABA and increases extracellular glutamate and dopamine
levels in the rat prefrontal cortex: an in vivo microdialysis study. Brain Res 948: 155–158
92 Verrico CD, Jentsch JD, Dazzi L, Roth RH (2003) Systemic, but not local, administration of
cannabinoid CB1 receptor agonists modulate prefrontal cortical acetylcholine efflux in the rat.
Synapse 48: 178–183
93 Gerdeman GL, Partridge JG, Lupica CR, Lovinger DM (2003) It could be habit forming: drugs
of abuse and striatal synaptic plasticity. Trends Neurosci 26: 184–192
94 Maingret F, Patel AJ, Lazdunski M, Honore E (2001) The endocannabinoid anandamide is a
direct and selective blocker of the background K(+) channel TASK-1. EMBO J 20: 47–54
95 Venance L, Piomelli D, Glowinski J, Giaume C (1995) Inhibition by anandamide of gap junctions
and intercellular clacium signalling in striatal astrocytes. Nature 376: 590–594
96 Zygmunt PM, Peterson J, Andersson DA, Chuang HH, Sorgard M, DiMarzo V, Julius D (1999)
Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 400:
452–457
97 Tognetto M, Amadesi S, Harrison S, Creminon C, Trevisani M, Carreras M, Matera M, Geppetti
P, Bianchi A (2001) Anandamide excites central terminals of dorsal root ganglion neurons via
vanilloid receptor-1 activation. J Neurosci 21: 1104–1109
98 Bidaut-Russell M, Devane WA, Howlett AC (1990) Cannabinoid receptors and modulation of
cyclic AMP accumulation in the rat brain. J Neurochem 55: 21–26
99 Howlett AC, Qualy JM, Khachatrian LL (1986) Involvement of Gi in the inhibition of adenylate
cyclase by cannabimimetic drugs. Mol Pharmacol 29: 307–313
100 Pacheco M, Childers SR, Arnold R, Casiano F, Ward SJ (1991) Aminoalkylindoles: Actions on
specific G-protein-linked receptors. J Pharmacol Exp Ther 257: 170–183
101 Bouaboula M, Poinot-Chazel C, Bourrie B, Canat X, Calandra B, Rinaldi-Carmona M, Le Fur G,
Casellas P (1995) Activation of mitogen-activated protein kinases by stimulation of the central
cannabinoid receptor CB1. J Biochem 312: 637–641
102 Wartmann M, Campbell D, Subramanian A, Burstein SH, Davis RJ (1995) The MAP kinase signal
transduction pathway is activated by the endogenous cannabinoid anandamine. FEBS Lett
359: 133–136
103 Caulfield MP, Brown DA (1992) Cannabinoid receptor agonists inhibit Ca current in NG108-15